Jamie Mackelfresh, MD: Currently, the CDC recommends that adults over age 50, in particular, are the core people who should think about getting the shingles vaccine. There are two different ...

Cohen's research is waiting for peer review and publication. There is a vaccine for shingles that's more than 90% effective but only about a quarter of eligible adults get it. "I'm hoping that we ...

Scientists have developed a vaccine for shingles, the unpleasant and often extremely painful condition which, it is estimated, affects around one third of the population at some point in their lives.

In our guide below, we’ll review the pros and cons of painting shingles and provide step-by-step instructions for you to complete this project. If your shingles are structurally sound ...

The print ads featured a prominent display of a person’s back, highlighting where shingles rashes typically emerge.

By Keith Roach, M.D. TITLE: 63-year-old debates getting shingles and chicken pox vaccines---DEAR DR. ROACH: A few months ago, yo ...

To help you determine whether solar roof shingles are worth the investment, we at the Guides Home Team have created this guide answering key questions and weighing the pros and cons. Solar ...

Shingles can be composed of a variety of materials, and each boasts its own pros, cons, and price points. Most types of roofing materials are priced by the square foot, and larger roofs require ...

Zero shingles cases after 18.8 months follow-up in 619 patients receiving any dose of amezosvatein, a development-stage adjuvanted subunit vaccine -- Ten shingles cases would have been expected absent ...

Solar panels can look bulky and detract from the beautiful aesthetic of your home. Solar shingles, on the other hand, integrate into your roof to create a more discreet solar system.

Nova Scotia's Progressive Conservatives promised on Tuesday to introduce a universal shingles vaccine program for people 65 and older if re-elected Nov. 26, the latest in a series of targeted ...

Zero shingles cases after 18.8 months follow-up in 619 patients receiving any dose of amezosvatein, a development-stage adjuvanted subunit vaccine -- Ten shingles cases would have been expected ...